News
InSyBio Suite Version 3.4 is announced, introducing a major upgrade of the InSyBio Interact tool for advanced protein interaction analysis and biological network discovery
InSyBio is thrilled to announce the release of InSyBio Suite Version 3.4, with a major upgrade to the InSyBio Interact tool, an advanced environment for protein analysis, protein–protein interaction (PPI) information retrieval, functional annotation, and biological network creation. InSyBio Interact v3.4 features improved PPI search capabilities supported by a comprehensive database of more than 2…Continue reading→
InSyBio Advances Understanding of Molecular Mechanisms Involved in Human Taste Using Machine-Learning and Network Analytics
A unique Machine-Learning and Molecular Modelling pipeline focusing on the interactome of the Taste Receptors has been released in a new publication from the InSyBio team in collaboration with a team of exceptional researchers from Dalle Molle Institute for Artificial Intelligence (Switzerland), and Politecnico di Torino (Italy) in the framework of VIRTUOUS Project, an EU…Continue reading→
InSyBio announces Novel of Multiple Taste Predictor based on a Multiobjective Machine Learning method
A novel predictor for multiple taste sensations based on a multi-objective Machine Learning method was published by InSyBio in the NPJ Science of Food journal of the Springer Nature publishing company (https://rdcu.be/dOVbA). This new predictor, namely Virtuous Multi-Taste, was developed in collaboration with a team of exceptional researchers from Politecnico di Torino (Italy), Industrial Systems…Continue reading→
InSyBio Harnesses the Power of Clinical Data developing AI tools for Cardiovascular Disease Treatment Optimization
Cardiovascular diseases (CVDs) are the leading cause of death globally, with 17.9 million annual deaths. InSyBio has partnered with Syndesis, the data and technology catalyst to a truly global, multi-continent network of healthcare and life sciences organizations, to address this enormous global health issue. We focused on two specific heart diseases, congestive heart failure (CHF)…Continue reading→
Position 1: Junior Software Engineer Developer
We are seeking a talented Junior software engineer with a Bachelor’s Diploma in Computer Engineering or any related diploma. The hired person will join our interdisciplinary team and work on the development and support of back-end functionalities of our biomedical data analysis platform, InSyBio Suite. Moreover, he/she will be trained to conduct data analysis of…Continue reading→
InSyBio Suite Version 3.2 is released including an integrated workflow and toolbox for single-cell RNA-sequencing analysis
Single-cell RNA sequencing is a powerful genomic method used to detect and analyze RNA molecules in biological samples at a single-cell level. It has proven successful in studying cell composition, proliferation, and migration. However, analyzing the data presents challenges due to standardization issues, data scarcity, and difficulties in integrating datasets with other sequencing technologies. The…Continue reading→
InSyBio recognized as the best Start-Up Initiative in 2023 at CPHI Pharma Awards
Barcelona, October 25th, 2023: CPHI Barcelona announced the winners of the prestigious 2023 CPHI Pharma Awards. The awards recognise outstanding achievements and contributions from the global pharma industry and supply chain across 12 wide-ranging categories. InSyBio won the best Start-Up Initiative in Pharma for 2023. CPHI is the biggest worldwide exhibition and event for the…Continue reading→
Syndesis Health and InSyBio Partner in Predictive Modelling and Biomarker Discovery
InSyBio, a leading biotechnology company that has developed a suite of advanced AI tools for biomarker discovery in clinical and multi-omics data, has announced a strategic partnership with Syndesis Health, a leader in global real-world evidence. The partnership aims to leverage the clinical and genomic data on Syntium, Syndesis’ data platform of global healthcare data, to accelerate…Continue reading→
InSyBio Suite Version 3.1 is released facilitating interactive and efficient network and machine-learning driven multi-omics data analysis
An increasing number of pharma and academic labs are getting access to multi-omics and multi-modal datasets. However, their processing requires multiple tools, while network analytics and data visualization can become challenging considering the high dimensionality, complexity and the presence of mutual information among different omics technologies. Moreover, predictive analytics using multi-omics data suffers from the…Continue reading→
Fitly Health & InSyBio have partnered to create the world’s first Metabolic AI™ precision nutrition program for metabolic syndrome, prediabetes, and Type 2 diabetes
Fitly Health has partnered with InSyBio to deliver life-changing outcomes for patients and employees with metabolic disorders who need to lose weight. Everyone has a unique metabolism and research now shows that our metabolic health is largely affected by diet-influenced changes to our gut microbiome. In other words, existing dietary interventions would be more effective in…Continue reading→